Wolff Wiese Magana »

Gt Biopharma shares owned by Wolff Wiese Magana

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Wolff Wiese Magana from 13F filings

Historical chart of Wolff Wiese Magana investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Wolff Wiese Magana consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Wolff Wiese Magana

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9k 5.0k 0.79

More positions owned by Wolff Wiese Magana

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Visa Com Cl A (V)
Ishares Tr Core S&p Scp Etf (IJR)
Abbvie (ABBV)
Apple (AAPL)
Vanguard Index Fds Real Estate Etf (VNQ)
American Express Company (AXP)
Amazon (AMZN)
Micron Technology (MU)
JPMorgan Chase & Co. (JPM)
Amgen (AMGN)
Cisco Systems (CSCO)
Raytheon Technologies Corp (RTX)

View all positions for Wolff Wiese Magana

Top funds holding Gt Biopharma

DRW Holdings
SeaCrest Wealth Management
Citadel Advisors
Geode Capital Management
Two Sigma Securities
Verdence Capital Advisors
Parsons Capital Management
Wells Fargo & Company
BlackRock
Advisor Group Holdings
Wolff Wiese Magana
Newbridge Financial Services Group
Farther Finance Advisors
Tower Research Capital
Spire Wealth Management

View all funds holding Gt Biopharma